Biochemical recurrence after radical prostatectomy: is the disease or the surgeon to blame?
Simsir, Adnan; Cal, Cag; Mammadov, Rashad; Cureklibatir, Ibrahim; Semerci, Bulent; Gunaydin, Gurhan.
Int. braz. j. urol
; 37(3): 328-335, May-June 2011. tab
Artículo en Inglés | LILACS | ID: lil-596007
Documentos relacionados
Index tumor location affected early biochemical recurrence after radical prostatectomy in patients with negative surgical margin: a retrospective study.
Large cribriform glands (> 0.25 mm diameter) as a predictor of adverse pathology in men with Grade Group 2 prostate cancer.
Survival outcomes of patients treated with local therapy for nonmetastatic prostate cancer with high prostate-specific antigen concentrations.
Validation of schedules for optimal prostate-specific antigen monitoring after radical prostatectomy.
Preoperative prostate health index predicts adverse pathology and Gleason score upgrading after radical prostatectomy for prostate cancer.
The 2012 Briganti nomogram not only predicts lymph node involvement but also disease progression in surgically treated intermediate-risk prostate cancer patients with PSA <10 ng/mL, ISUP grade group 3, and clinical stage up to cT2b.
Surgical Outcome of Open Radical Prostatectomy in Nigeria: A Five-Years Single-Surgeon Experience.
Changing nationwide trends away from overtreatment among patients undergoing radical prostatectomy over the past 25 years.
The effect of a fermented soy beverage among patients with localized prostate cancer prior to radical prostatectomy.
Role of cytoreductive radical prostatectomy in men with oligometastatic prostate cancer on molecular imaging.